Covaxin moves to next stage of trialsIndia is likely to overtake Brazil as the second worst affected country in a day as the covid-19 case count rises steadily.
Over 90,600 new cases were reported on Sunday, taking the total infections past 41.13 lakh. This is despite having a recovery rate of 77%.
Bharat Biotech, which is working on an indigenous covid-19 vaccine Covaxin, has received approval to move to phase 2 of human testing, and the trials on 380 volunteers are likely to begin this week.
Others, including ZydusCadila and Serum Institute are conducting phase 2 trials already. Russia has said it is likely to release its Sputnik V vaccine for civilian use this week.